Publikationen in Zusammenarbeit mit Forschern von Texas Children's Hospital (2)

2024

  1. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study

    Pediatrics, Vol. 153, Núm. 3

2011

  1. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283